Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Trichoblastomas in aged house musk shrews show unique features and may involve serum amyloid A in inflammation.

Chronic bacterial infections of hair follicles can cause ongoing skin inflammation.

Blocking Oncostatin M's role in the JAK-STAT pathway can stimulate hair growth in mice.

The document suggests a rare skin condition might be caused by a genetic phenomenon.

Melanin granules can be expelled by exocytosis.

Atypical symptoms in lupus can indicate different kidney issues.

People with Alopecia Areata and Androgenic Alopecia have more mast cells in their scalp than healthy individuals, especially those with Alopecia Areata.

Methotrexate effectively controls eye inflammation in Japanese patients with non-infectious uveitis but requires careful monitoring for side effects.

JAK inhibitors help regrow hair in alopecia areata patients, improving their quality of life.

A patient had both chronic lupus and systemic scleroderma, requiring careful treatment to manage symptoms.

Alopecia areata may be caused by the immune system attacking hair follicles.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

A patient with untreated congenital adrenal hyperplasia had large benign tumors in her adrenal glands removed, improving her symptoms.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Tofacitinib treatment for hair loss may worsen acne.

A pancreatic tumor caused high glucagon levels and symptoms, but treatment reduced glucagon and shrank liver tumors.

The red panda's hair loss was caused by an endocrine issue linked to ovarian tumors.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

Diabetic wounds heal slower than healthy wounds.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

Itraconazole-loaded nanoparticles are more effective and less toxic for treating fungal infections than conventional oral itraconazole.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Treatment reduced cystic lesions but didn't change existing Nevus Comedonicus.

Two patients with lupus had an unusual type of hair loss not typical for the disease but improved with treatment.

Topical tofacitinib may help regrow hair in children with alopecia totalis.

Removing a tumor may resolve associated skin and hair symptoms.